Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
Singular Genomics Systems, Inc. (OMIC)
Company Research
Source: Yahoo! Finance
sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the fourth quarter and full year ended December 31, 2023. “We ended 2023 on a strong note, shipping our largest number of quarterly instruments to-date,” said Drew Spaventa, Chairman and Chief Executive Officer of Singular Genomics. “We continue to build momentum in early 2024 with the recent unveiling of the G4X, the first in situ spatial sequencer. The G4X brings sequencing into tissue sections, offering new capabilities and novel data streams with industry-leading throughput and cost.” Fourth Quarter and Recent Financial Highlights Generated revenue of $1.1 million in the fourth quarter of 2023, representing growth of 41% compared to prior year period and 134% compared to the third quarter of 2023. Shipped eight G4 systems in the fourth quarter of 2023, increasing the total number of commercial systems
Show less
Read more
Impact Snapshot
Event Time:
OMIC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OMIC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OMIC alerts
High impacting Singular Genomics Systems, Inc. news events
Weekly update
A roundup of the hottest topics
OMIC
News
- Singular Genomics Systems, Inc. (NASDAQ: OMIC) had its price target raised by analysts at UBS Group AG from $0.40 to $0.50. They now have a "neutral" rating on the stock.MarketBeat
- Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial ResultsGlobeNewswire
- Healthcare and Life Sciences Industries Look to AI and Automation to Boost Growth and Productivity, According to Clari and FiercePharma Study [Yahoo! Finance]Yahoo! Finance
- Singular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 [Yahoo! Finance]Yahoo! Finance
OMIC
Earnings
- 11/14/23 - Beat
OMIC
Sec Filings
- 4/18/24 - Form ARS
- 4/18/24 - Form DEFA14A
- 4/18/24 - Form DEF
- OMIC's page on the SEC website